Breaks Categories: News

TuesdayMar 21, 2017 9:58 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Files Provisional Patent for Treatment of Eating Disorders Using Cannabis Extracts

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its filing of a provisional patent for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds. Should this filing result in the issuance of a patent, IGC intends to develop its IGC-506 candidate for both human and veterinary use. “The development of cannabis-based combination therapies represents a large, unique opportunity, and we believe we are the first mover in this emerging specialty-pharmaceutical sector,” Ram Mukunda, chief executive officer…

Continue Reading

ThursdayMar 16, 2017 12:35 pm

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article

India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company's strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore. That focus changed a few years ago when iron ore prices plummeted, often selling below its cost of production. For the last three years, the company has shifted its focus to tackling the cannabis industry, or more specifically, medical cannabis use. The company is currently developing a portfolio to address epilepsy, cachexia, PTSD, Alzheimer’s, and Parkinson’s. “We came up…

Continue Reading

ThursdayMar 16, 2017 10:40 am

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Announces Engagement of CannabisNewsWire

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) this morning announced its engagement of CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, CNW will look to generate greater brand awareness for Player’s Network as the company seeks to expand its presence in both the media and cannabis industries. “This partnership is an extension of our new shareholder…

Continue Reading

TuesdayMar 14, 2017 10:12 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Expands Presence in Cannabis Industry through Acquisition of Stake in Convectium

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has closed its first round of funding to acquire a stake in Jacksam Corp., dba Convectium, the developer of a unique oil filling system poised to revolutionize the cannabis industry. Originally announced at the end of January, the Convectium acquisition is expected to include an overall investment of stock and cash consideration totaling $800,000, which Convectium will use to help fund its growth as well as marketing of its revolutionary 710Shark and 710Seal system. Leaning on the marketability of the first-of-its-kind system, as well as its line of…

Continue Reading

FridayMar 03, 2017 11:21 am

CannabisNewsBreaks – NEMUS Bioscience, Inc. (NMUS), Catalent to Advance Development of NB1222 Human Dosage Formulation

NEMUS Bioscience (OTCQB: NMUS) this morning said it is moving forward with Catalent Pharma Solutions to advance development of a human-dosage suppository formulation of NB1222. NB1222 is the proprietary prodrug of tetrahydrocannabinol (THC) being developed for the treatment and management of chemotherapy-induced nausea and vomiting (CINV). NB1222, also known as the prodrug THC-valine-hemisuccinate, is synthetically manufactured and is not plant-derived. "The global CINV market is a multi-billion dollar opportunity with projected growth as populations live longer, increasing the likelihood of developing a malignancy over time," Nemus CEO and chief medical officer Brian Murphy, M.D. stated in the news release. To…

Continue Reading

ThursdayFeb 16, 2017 9:37 am

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Uplists to the OTCQB Venture Market

Diversified holding company Player’s Network, Inc. (OTCQB: PNTV) this morning announced that its common shares are now trading on the OTCQB Venture Market, effective February 16, 2017. In order to be eligible for listing on the OTCQB Venture Market, which is designed for entrepreneurial and development-stage companies, Player’s Network was required to be current in its financial reporting and undergo an annual company verification and management certification process. “We are proud to announce this corporate milestone as we execute our plan to add tenure to our 23-year track record as a fully reporting company,” Mark Bradley, CEO of Player’s Network,…

Continue Reading

MondayFeb 13, 2017 9:20 am

CannabisNewsBreaks – ChineseInvestors.com (CIIX) Issues Update on Recent Financial and Business Achievements

ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning issued a news release highlighting some of its financial and business achievements for January 2017, as well as its plans to build on these milestones moving forward. After reporting significantly higher revenues for the three- and six-month periods ended November 30, 2016, the company has now achieved revenue growth for three consecutive quarters, and ChineseInvestors.com will look to continue this trend through its entry into the hemp-based cannabidiol (CBD) health products market. In addition to completing a $5 million private placement, the company kicked off 2017 with the launch of its new www.ChineseCBDoil.com site,…

Continue Reading

TuesdayFeb 07, 2017 9:50 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Announces Position as a Debt-Free Company

Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning announced that it is now officially debt-free. The milestone comes as a result of the company’s ongoing fundraising initiatives, which have already resulted in the addition of more than $300,000 of working capital to its balance sheet. SinglePoint has also entered into a Letter of Intent stemming from these efforts that’s expected to result in the securement of $1 million of additional funding. Per this morning’s update, SinglePoint intends to use the capital from these fundraising efforts to support its proposed uplisting to the OTCQB Venture Market later…

Continue Reading

TuesdayJan 31, 2017 10:50 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) to Acquire Stake in Convectium, Creator of Cannabis Industry’s First-of-its-Kind Oil Filling Machine

SinglePoint (OTC: SING), a full-service mobile technology and marketing provider, this morning announced its LOI to acquire an interest in Convectium, the creator of a unique oil filling machine capable of filling cartridges or disposable vape pens for wholesale distribution to dispensaries. Convectium’s 710Shark and 710Seal system can fill and package up 100+ cartridges or disposable vape pens in 30 seconds. “To say we are excited about this opportunity is an understatement. Convectium's 710Shark and 710Seal system is incredible, and its capabilities are unmatched. After looking at hundreds of cannabis companies, finding an acquisition opportunity like we have found in…

Continue Reading

MondayJan 09, 2017 12:58 pm

CannabisNewsBreaks – Medical Marijuana, Inc. (MJNA) Reports Positive Data on CanChew Plus® CBD Gum by AXIM® Biotechnologies, Inc. (AXIM)

Shares of Medical Marijuana (OTC: MJNA) are ticking higher after the company said its major investment company, AXIM® Biotechnologies (OTC: AXIM), received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials as treatment for irritable bowel syndrome (IBS). The single dose study conducted to determine the concentration of CBD in the blood after chewing one CanChew Plus® Gum for 30 minutes showed positive results for the 30 mg dosage. This data will be used to determine the optimal concentration in the IBS patient trial. AXIM aims to provide a pharmaceutical…

Continue Reading